Lumason is a Intravenous; Intravesical Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Distearoylphosphatidylcholine, Dl-; Sodium 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol); Sulfur Hexafluoride.
| Product ID | 0270-7097_0730c3bf-1564-4cb0-88ce-430be8b835f0 |
| NDC | 0270-7097 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lumason |
| Generic Name | Sulfur Hexafluoride |
| Dosage Form | Injection, Powder, Lyophilized, For Suspension |
| Route of Administration | INTRAVENOUS; INTRAVESICAL |
| Marketing Start Date | 2021-04-01 |
| Marketing Category | NDA / |
| Application Number | NDA203684 |
| Labeler Name | BRACCO DIAGNOSTICS INC |
| Substance Name | DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE |
| Active Ingredient Strength | 0 mg/mg; mg/mg; mg/mg |
| Pharm Classes | Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0270-7097 | Lumason | SULFUR HEXAFLUORIDE |
| 0270-7099 | LumaSon | SULFUR HEXAFLUORIDE |
| 68155-099 | LumaSon | SULFUR HEXAFLUORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LUMASON 88284789 5834181 Live/Registered |
Bracco Diagnostics Inc. 2019-01-31 |
![]() LUMASON 85929727 4786320 Live/Registered |
Bracco Diagnostics Inc. 2013-05-13 |